Allergan moves in as Shire rebuffs $63 billion Takeda bid: sources

NEW YORK/LONDON (Reuters) - Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan's Takeda Pharmaceutical , although talks are continuing, while sources said Allergan was also in competing negotiations.

Allergan moves in as Shire rebuffs $63 billion Takeda bid: sources
Read More


Bagikan Berita Ini